Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05139290 · ClinicalTrials.gov registry record · NA
DECIDE: Dyads and Families
A NA study of Alzheimer Disease and Dementia, sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 4
- Study locations
NCT05139290 is a NA study of Alzheimer Disease and Dementia that is actively recruiting participants, run by Emory University. The registered enrollment target is 40 participants, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (99% lower). The trial reports 4 study locations across 2 states.
The verdict
NCT05139290, a NA study of Alzheimer Disease and Dementia, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to design and test a decision-making program that is tailored to support adult daughters making healthcare decisions for their parents who are living with memory loss to improve the quality of life of African American families. There are two phases of this research study. The first phase will collect information by surveys and/or interviews. The surveys and interviews will ask questions about demographics (e.g., age, race/ethnicity), culture, health, family dynamics, caregiving, and healthcare experiences. The surveys will be completed by all eligible adult daughters and parents with memory loss in pairs. The interviews will be completed by a smaller number of pairs and by all former adult daughter caregivers. The general scope of topics is caregiving experiences, cultural identity, healthcare decisions for persons living with Alzheimer's disease, and related dementias, health, and well-being. The research team will identify and examine key factors that will lead to designing and testing the feasibility of a culturally tailored prototype intervention for African American dementia dyads/families of persons living with mild to moderate Alzheimer's disease and related dementias.
Conditions Studied
Interventions
- BEHAVIORAL Prototype Intervention
Study Locations (4)
Georgia
- Emory Healthcare Integrated Memory Care Clinic - Atlanta
- Emory University Goizueta Alzheimer's Disease Research Center Minority Engagement Core - Atlanta
- Metro-Atlanta - Atlanta
District of Columbia
- Zeta Phi Beta Sorority, Inc. - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-07-15 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05139290
The ClinicalTrials.gov registry entry for NCT05139290 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (99% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which Prototype Intervention is the first listed.
NCT05139290 reports 4 study locations spanning 2 distinct geographic areas - top geographies include Georgia, District of Columbia.
Frequently Asked Questions
What is clinical trial NCT05139290 about?
NCT05139290 is a clinical study titled "DECIDE: Dyads and Families". The purpose of this study is to design and test a decision-making program that is tailored to support adult daughters making healthcare decisions for their parents who are living with memory loss to improve the quality of life of African American families. There are two phases of this research stud...
What is the current status of trial NCT05139290?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2022-07-15. Estimated completion is 2026-12.
What conditions does trial NCT05139290 study?
This clinical trial studies the following conditions: Alzheimer Disease, Dementia, Caregiver Burden.
What interventions are being tested in trial NCT05139290?
The interventions under investigation include: Prototype Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05139290?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05139290 being conducted?
This trial has 4 study locations across District of Columbia, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
RECRUITING · NA
-
Brain Outcomes With Lifestyle Change in Down Syndrome
RECRUITING · NA
-
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
RECRUITING · NA
-
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
RECRUITING · NA
-
Connect-Home: Alzheimer's Disease and Related Dementias
RECRUITING · NA
-
Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.